Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study (NCT06149650)
🩺 Plain-English Summary (8th-Grade Level)
CALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to disrupt calcified femoropopliteal and crural lesions in patients with chronic limb-threatening ischemia (CLTI). The primary objective of CALCIO is to understand the effectiveness of IVL in promoting wound healing and preventing amputation. The secondary objectives of CALCIO are to evaluate the immediate effectiveness of the treatment in restoring vessel patency as well as its safety and impact on patients' quality of life.
Who can join: Review the eligibility criteria below.
Location: Krankenhaus der Barmherzigen Brüder — Eisenstadt
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (39 Sites)
Showing the first 25 of 39 sites.
- Krankenhaus der Barmherzigen Brüder — Eisenstadt,
- Medizinische Universität Graz — Graz,
- Krankenhaus Barmherzige Brüder Linz — Linz,
- Klinik Hietzing — Vienna,
- Klinik Florisdorf — Vienna,
- Hôpital Sacré Coeur de Montréal — Montreal,
- CHU François Mitterrand — Dijon,
- Institute Mutualiste Montsouris — Paris,
- Rhéna Clinique de Strasbourg — Strasbourg,
- Universitätsklinikum Köln — Cologne,
- Universitätsmedizin Essen — Essen,
- KRH Klinikum Robert Koch Gehrden — Hanover,
- SLK-Heilbronn — Heilbronn,
- Städtisches Klinikum — Karlsruhe,
- Evangelisches Krankenhaus — Mülheim,
- Friedrich Ebert Krankenhaus — Neumünster,
- Schön Klinik Rendsburg — Rendsburg,
- St Marien-Krankenhaus — Siegen,
- Universitätsklinikum Tübingen — Tübingen,
- Semmelweis University — Budapest,
- Hospital General Universitario Dr. Balmis — Alicante,
- Hospital General de Granollers — Granollers,
- University of Navarra — Pamplona,
- Ente Ospedaliero Cantonale — Lugano,
- Kantonsspital Winterthur — Winterthur,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Limb-Threatening Ischemia
- Esprit BTK Post-Approval Study — Scottsdale, Arizona
- BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI) — San Francisco, California
- Peripheral Bypass Trial for Completion Control — San Francisco, California
- Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease — New York, New York
Explore by condition: All Chronic Limb-Threatening Ischemia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.